ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 170 filers reported holding ALLOGENE THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 1.82 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $78,785 | -32.8% | 24,853 | +5.4% | 0.00% | – |
| Q2 2023 | $117,173 | -99.3% | 23,576 | -96.1% | 0.00% | -100.0% |
| Q4 2019 | $15,866,000 | -26.2% | 610,697 | -22.6% | 0.01% | -33.3% |
| Q3 2019 | $21,498,000 | +1.5% | 788,779 | 0.0% | 0.01% | +9.1% |
| Q2 2019 | $21,179,000 | -6.4% | 788,779 | -0.0% | 0.01% | -8.3% |
| Q1 2019 | $22,616,000 | +68.2% | 788,979 | +58.1% | 0.01% | +50.0% |
| Q4 2018 | $13,443,000 | – | 499,182 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 1,798,163 | $5,700,177 | 8.82% |
| Wildcat Capital Management, LLC | 1,920,787 | $6,088,895 | 2.44% |
| TPG GP A, LLC | 18,716,306 | $59,330,690 | 1.02% |
| EcoR1 Capital, LLC | 4,488,200 | $14,227,594 | 0.48% |
| CROSSPOINT FINANCIAL, LLC | 12,000 | $38,040 | 0.40% |
| Coastal Bridge Advisors, LLC | 406,847 | $1,289,705 | 0.35% |
| CAXTON ASSOCIATES LP | 480,104 | $1,521,930 | 0.21% |
| Woodline Partners LP | 5,313,915 | $16,845,111 | 0.20% |
| Rhenman & Partners Asset Management AB | 300,000 | $951,000 | 0.10% |
| Navalign, LLC | 75,365 | $238,907 | 0.09% |